Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Beyond the apnea-hypopnea index: Precision cardiovascular risk stratification in obstructive sleep apnea.
Journal: American journal of preventive cardiology
Published: May 23, 2026
Efficacy and safety of olezarsen in patients with vs without baseline fibrate use.
Journal: Journal of clinical lipidology
Published: May 13, 2026
DOTA-based perfusion imaging in hybrid positron emission tomography/magnetic resonance: Promise, limits, and the importance of tracer kinetics.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: March 19, 2026
Blunted heart rate response to regadenoson predicts cardiovascular risk beyond quantitative positron emission tomography myocardial blood flow.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: February 16, 2026
Sacubitril/Valsartan versus Enalapril or Losartan at Maximum Doses in Heart Failure with Reduced Ejection Fraction: Real-World Data.
Journal: Arquivos brasileiros de cardiologia
Published: February 04, 2026
Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis.
Journal: Diabetes, obesity & metabolism
Published: January 20, 2026
A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network in Cardiometabolic Health and Type 2 Diabetes.
Journal: Circulation research
Published: January 15, 2026
Low-Dose CT as a Diagnostic Clue: Unmasking Anemia as a Cause of Reduced Myocardial Flow Reserve on PET/CT.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: December 09, 2025
A Multicenter Randomized Clinical Trial of Dapagliflozin in Patients Receiving Chronic Dialysis (The DARE-ESKD-2 Trial).
Journal: Kidney international reports
Published: November 25, 2025
Common genetic variants near SLC2A2 and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trial.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.
Journal: The New England journal of medicine
Published: November 10, 2025
Last Updated: 09/26/2026